Related Experiment Video
Updated: Feb 19, 2026
Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
Mortality as an outcome in hospital-acquired pneumonia
1Intensive Care Department, Hospital de Sabadell, Barcelona, Spain. jrello@siberia.chpt.es
Abstract:
The most common route of entry of pathogens into the lung in patients managed in the intensive-care unit is aspiration of contaminated oropharyngeal secretions or gastric contents. In intubated patients, the risk of this type of infection is particularly high. Knowledge of specific risk factors for specific microorganisms, along with the origin of acquisition (primary endogenous, secondary endogenous, or exogenous), will permit a more rational and effective method of prevention. Attributable mortality is highly dependent on the institution of a correct initial antibiotic choice, as well as the interaction between the virulence of the pathogen responsible and host defenses. However, survival in these patients is determined primarily by the degree of severity at the time of pneumonia diagnosis and the response to initial therapy. As a consequence, the number of preventable deaths is likely to be much smaller than the total. Therapy requires both supportive and specific measures. When diagnostic information becomes available, it permits the rescue of some patients with inadequate therapy or simplifies the spectrum of the empirical therapy. Initial antibiotic choice should be based on expected etiologic pathogens, while knowledge of local microbial epidemiology and susceptibility patterns is crucial.
Insights
Preventing hospital-acquired pneumonia in intensive care units (ICUs) involves understanding pathogen entry routes like aspiration. Effective prevention and treatment strategies are crucial for patient survival, though many deaths may not be preventable.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonology
Background:
- Hospital-acquired pneumonia (HAP) is a significant risk in intensive care units (ICUs).
- Aspiration of oropharyngeal secretions or gastric contents is the primary route of lung pathogen entry in ICU patients.
- Intubated patients face a particularly high risk of developing HAP.
Purpose of the Study:
- To explore risk factors and acquisition origins of microorganisms causing HAP in ICUs.
- To emphasize the importance of rational prevention strategies for HAP.
- To analyze factors influencing mortality and survival in ICU patients with pneumonia.
Main Methods:
- Review of common pathogen entry routes into the lungs in ICU settings.
- Analysis of risk factors associated with specific microorganisms and their acquisition.
- Evaluation of the impact of initial antibiotic choice, pathogen virulence, and host defenses on outcomes.
- Assessment of the role of disease severity and treatment response in patient survival.
Main Results:
- Understanding pathogen sources (endogenous or exogenous) aids in developing effective prevention.
- Attributable mortality is linked to initial antibiotic selection and pathogen-host interactions.
- Patient survival is predominantly determined by pneumonia severity at diagnosis and treatment response.
Conclusions:
- Rational prevention of HAP requires knowledge of specific microbial risks and acquisition pathways.
- Optimal initial antibiotic therapy, guided by local epidemiology and susceptibility, is critical.
- While some deaths are preventable, overall survival hinges on prompt diagnosis and effective treatment.
More Related Videos
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:29Pneumonia II: Pathophysiology
01:21Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...